Merit Medical Systems | MMSI - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
3M USD 4.92B 10M 2025-12
Abbott USD 9.21B 17M 2025-12
AngioDynamics USD 81.95M 1.68M 2025-09
Anika Therapeutics USD 29.97M 116.84M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Hologic USD 349.4M 447.1M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 18.97B 2.38B 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Olympus JPY 233.04B 18.77B 2025-12
Pfizer USD 12.91B 79.89B 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD -245.35M 363.49M 2024-09
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12